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Background: The aim of this study was to determine the prevalence of different
autoantibodies (aAbs) in adult French cystic ﬁbrosis (CF) patients and to look for
a correlation between autoimmunity, patient characteristics and survival.
Methods: The sera of 144 patients were screened for a wide range of Abs. Clinical,
biological and bacteriological characteristics and CFTR genotype were recorded and
progression of lung disease was examined.
Results: One hundred and thirteen patients (78.5%) displayed one or several aAbs,
predominantly IgA anti-Saccharomyces cerevisiae antibodies (ASCA IgA) (43.7%)
and anti-neutrophil cytoplasmic antibodies (ANCA) (40%), of which 59% showed
bactericidal/permeability-increasing protein (BPI) speciﬁcity. The presence of BPI-
ANCA was associated with the number of antibiotic courses, low body mass index,
P aeruginosa colonisation, presence of resistant P aeruginosa, low FEV1, CF-
related liver disease, hypergammaglobulinaemia, male gender and inﬂammatory
syndrome. The presence of ASCA IgA was correlated with male gender and
hypergammaglobulinaemia. Forty-one patients presented chronic respiratory failure
and/or requested lung transplantation or died during follow-up. These events were
more frequent in patients with BPI-ANCA or ASCA IgA.
Conclusion: These ﬁndings conﬁrmed the high frequency of aAbs in CF, partic-
ularly BPI-ANCA and ASCA IgA, and the link between BPI-ANCA, severity of
lung disease and CF prognosis.
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CF bronchial infections are accompanied by neutrophil inﬂammation and elevated
IL-8 response. The ﬁndings that lungs of CF patients are structurally normal at
birth, CF airway epithelia fail to kill bacteria, signs of inﬂammation are apparent
in BAL are suggesting that hyperinﬂammation is directly related to the lack of
the affected gene product, the CFTR protein. However many previous BAL studies
classiﬁed subjects as “infected” if a certain amount of identiﬁed pathogens was
exceeded and agents considered to be nonpathogenic, were also associated with
increased inﬂammation. This might explain why inﬂammation has apparently been
documented in the absence of infection.
In 2 recent studies with CF infants without any sign of infection it was found that the
BAL proﬁles for inﬂammatory parameters was comparable to a control group and
that there was no hyperinﬂammation in CF, suggesting that solely the mechanisms
underlying the control of inﬂammation, as well as responses to infection, may be
compromised in CF.
CFBE41o- and its identical stably CFTR corrected counterpart were compared and
we found in the corrected cell line that IL-8 and IL-6 secretions were increased after
LPS stimulation and that this effect could be speciﬁcally inhibited by antibodies
and siRNA directed against TLR-4. FACS analysis revealed signiﬁcantly higher
levels of TLR-4 surface expression in corrected cells. In lung sections of healthy
controls the TLR-4 expression in the bronchial epithelium was signiﬁcantly higher
compared to CF patients.
We suppose that the loss of CFTR function appears to decrease the innate immune
responses in CF, possibly by altering the expression of TLR-4 on epithelial cells.
This may contribute to bacterial infection and airway obstruction.
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Dysregulation of inﬂammation pathway observed in CF patient’s airways, associated
with chronic lung infections, leads to a progressive destruction of pulmonary
parenchyma. We have previously identiﬁed COMMD1 and CSN5 as new CFTR
partners. COMMD1 and CSN5 are involved in multiple cellular processes, including
NF-úB and TGFb pathways. TNFa, IFNg and TGFb have been shown to decrease
the amount of CFTR mRNA. We aimed to study the role of COMMD1 and CSN5
on CFTR gene transcription in bronchial epithelial cells, given the three subsequent
points:
i. CSN5, also known as Jab 1 (Jun activating binding protein), promotes the
production of AP-1 protein, involved in inﬂammation. Moreover, AP-1 activity
is increased in CF cells.
ii. COMMD1 interferes with NF-úB transcriptional activity by destabilizing
chromatin/NF-úB interaction and, NF-úB is overexpressed in CF cells.
iii. The CFTR gene contains one úB-responsive element and at least four AP-1
binding sites.
We have shown a different COMMD1 and CSN5 nucleocytoplasmic distribution
between CF (IB3−1) and non CF cells (S9). 5′ deletion analysis of the CFTR
promoter was performed using ten different constructs encompassing 4000 bp
upstream the transcription start site. Functional assays were performed by luciferase
tests in different conditions, over and down-expression of both proteins.
Our results suggest that COMMD1 and CSN5 might be new regulators of CFTR
transcription and will give clues to CFTR downregulation observed in inﬂammatory
conditions.
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Chronic lung infection with Pseudomonas aeruginosa is the most severe com-
plication for patients with cystic ﬁbrosis (CF). This infection is characterized
by endobronchial mucoid bioﬁlms surrounded by numerous polymorphonuclear
leukocytes (PMNs). The mucoid phenotype offers protection against the PMNs,
which are in general assumed to mount an active respiratory burst leading to lung
tissue deterioration. Recent evidence for accelerated depletion of molecular oxygen
by the respiratory burst of the PMNs in the mucus in infected CF bronchi has
inspired our hypothesis that the PMNs are well equipped to survive and perform
without oxygen.
To test the hypothesis, normal human PMNs were isolated and incubated for 1
to 4 days in ambient air or in an anaerobic bench before estimating membrane
integrety, apoptosis, respiratory burst and migration. Signiﬁcantly more intact PMNs
and less apoptotic PMNs were seen from day 1 in the samples incubated without
oxygen. In addition, PMNs incubated without oxygen showed a signiﬁcantly higher
respiratory burst and ability to migrate from day 1.
These results demonstrate that PMNs are well adapted to survive and function
without oxygen mitochondrial aerobic respiration and suggests a mechanism that
contributes to the dominant accumulation of this particular leukocyte subpopulation
in anaerobic compartments such as parts of the mucus in infected CF bronchi.
